Skip to main content

Closed

CRMD: CorMedix Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Operating margin48.4%

ROIC27.6%

Financially safe

Strong

Debt / equity0.34×

Interest coverage69.9×

Current ratio2.98×

Valuation

Unrated

P/E ratio3.2×

CorMedix Inc.

CRMDNASDAQ Global Market·USD·Closed

CorMedix Inc.

CRMDNASDAQ·USD·Closed

$7.53

+0.53%

$7.53

+$0.04 (0.53%)

52W Range

16thpctl

Volume

0.47×avg

Mkt Cap

590.74MUSD

P/E

3.2TTM

Div Yield

–ann

52W Range

16thpctl

Volume

0.47×avg

Market Cap

590.74MUSD

P/E Ratio

3.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings